Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
about
The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden.Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization.Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c miceSuppression of IL-8 production in gastric epithelial cells by MUC1 mucin and peroxisome proliferator-associated receptor-γ.A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.Vaccinating against Helicobacter pylori in the developing world.Inflammation, immunity, and vaccines for Helicobacter pylori infection.Why can't we make an effective vaccine against Helicobacter pylori?STAT3: a critical component in the response to Helicobacter pylori infection.Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5.Vaccine-mediated protection against Helicobacter pylori is not associated with increased salivary cytokine or mucin expression.
P2860
Q34638090-793EAB94-EC8A-4C1F-9BCF-63BCAF6E3F2EQ34854083-B66A4BA9-8E58-4A6F-B52A-AB51E75E3F50Q35082439-8071E9E0-D7BA-42B5-A5D0-43E8D6B4BE65Q35914868-52D99209-5572-42F1-89FB-A48AB936F1C5Q36120631-A51182E9-9E54-44B2-9C7A-4C86FD404AB0Q36309498-6EC853A4-6DE5-43F1-BEF5-17CA077776DAQ36826907-BD4131BE-CD08-478F-B993-D3D58EC648B0Q37591512-11C0E365-3A6F-4D1A-AEA7-F15D0891E7EFQ38041639-7F866C1F-AD10-4E48-B9CB-81301D2123A4Q38096493-C3173E0C-892C-4A9D-ADC1-D103B94F5BF6Q38579179-71E65917-5E27-43D6-8530-3334510D0A89Q40525875-BBA16B10-907A-4999-B13E-CA5D7B197B84Q41482482-DADF0C67-DEBA-46D1-950F-B90E6D73BBC8Q44532534-05E9AE80-0E3D-4491-AFAC-4B8D8FA5E4EAQ45141825-222CAE99-71F7-4BD8-B207-70F388D08DE2Q45745198-1A3FFB2A-BFDD-48AF-92B1-16ECADFEA5AA
P2860
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
@ast
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
@en
type
label
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
@ast
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
@en
prefLabel
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
@ast
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
@en
P2093
P2860
P1433
P1476
Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
@en
P2093
Elizabeth S DeLyria
Jinghua Xu
John G Nedrud
Mohammad S Alam
Peter B Ernst
Raymond W Redline
Steven J Czinn
Thomas G Blanchard
P2860
P304
P356
10.1111/J.1523-5378.2011.00839.X
P577
2011-06-01T00:00:00Z